Evidence map›Paper›PMID 42396191›Full record

ArticleChinese medical journal pulmonary and critical care medicine2026

Respiratory microbiota transplantation: optimized framework and its impact on metabolic and immune characteristics.

Shifen Xu, Xing Zhang, Yunfeng Shi, Xiang Tan, Hanqin Cai, Wei Cheng, Lei Yang, Xinzhu Yi, Zhiming Xiang, Chao Cao and 2 more

Abstract read
In one paragraph

Article in Chinese medical journal pulmonary and critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shifen XuGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome; School of Life Sciences, South China Normal University, Guangzhou, Guangdong 510631, China.
Xing ZhangYu-Yue Pathology Scientific Research Center, Jinfeng Laboratory, Chongqing 401329, China.
Yunfeng ShiGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome; School of Life Sciences, South China Normal University, Guangzhou, Guangdong 510631, China.
Xiang TanCollege of Animal Sciences and Technology, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
Hanqin CaiGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome; School of Life Sciences, South China Normal University, Guangzhou, Guangdong 510631, China.
Wei ChengCollege of Animal Sciences and Technology, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
Lei YangGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome; School of Life Sciences, South China Normal University, Guangzhou, Guangdong 510631, China.
Xinzhu YiGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome; School of Life Sciences, South China Normal University, Guangzhou, Guangdong 510631, China.
Zhiming XiangDepartment of Radiology, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, Guangdong 511400, China.
Chao CaoDepartment of Respiratory and Critical Medicine, Key Laboratory of Respiratory Disease of Ningbo, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China.
Hong WeiYu-Yue Pathology Scientific Research Center, Jinfeng Laboratory, Chongqing 401329, China.
Zhang WangGuangdong Engineering Research Center of Precision Detection and Modulation of Human Microbiome, School of Life Sciences, State Key Laboratory of Respiratory Disease, South China Normal University, Guangzhou, Guangdong 510631, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The respiratory microbiota is critical to maintaining local immune homeostasis and respiratory health. Microbiota transplantation has proven transformative in gut microbiome studies. However, a standardized approach for the respiratory tract remains lacking, hindered by technical difficulty of establishing a recipient airway niche conducive to stable donor microbial engraftment, and limited systematic evaluation of key parameters that influence transplantation efficacy. This study aims to establish an optimized respiratory microbiota transplantation (RMT) framework and determine whether RMT reshapes metabolic and immunological characteristics. Methods: We developed and optimized a method for RMT in murine models. Key parameters, including sample storage, delivery route, and treatment regimen, were systematically evaluated for their effects on the microbiome using 16S ribosomal RNA gene sequencing-based profiling. The influence of microbiota transplantation on host metabolism and immunity was also assessed through metabolomic and transcriptomic characterization. Wilcoxon rank-sum test was used to compare Bray-Curtis dissimilarity between groups. Additionally, a one-sample Wilcoxon signed-rank test was used to determine whether the relative abundance changes within each recipient-donor pair significantly deviated from zero. Differential metabolomic and transcriptomic features were identified using trend analysis. Results: We established mouse-to-mouse RMT by transferring bronchoalveolar lavage fluid (BALF)-derived microbial communities from specific pathogen-free (SPF) donors to germ-free (GF) recipients. To model lung dysbiosis, we induced sepsis via cecal ligation and puncture in SPF mice and transplanted their BALF microbiota into normal SPF recipients. The highest compatibility of donor-recipient microbiota was observed using glycerol-preserved samples, delivered either intratracheally or intranasally every other day, for a duration of 14 days (Wilcoxon rank-sum test, SPF-GF mice: intratracheal delivery 7 days Conclusion: Our study establishes an optimized protocol for RMT using glycerol-preserved samples, delivered either intratracheally or intranasally every other day over 14 days. This approach should empower preclinical investigation of respiratory microbiota and pave the way for clinical translation.

Indexed as

Germ-free miceMicrobiota transplantationMulti-omicsRespiratory microbiome

Identifiers

PMID42396191
PMCPMC13323557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.